Optimax Access Revenue
Hospitals and Health Care • 
Southampton, England, United Kingdom • 11-20 Employees
Optimax Access revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Key Contacts at Optimax Access
Mehdi Javanbakht
Founder And Managing Director
Amir Ansaripour
Director Heor
Company overview
| Headquarters | University of Southampton Science Park, Southampton, Hampshire SO16 7NS, GB |
| Phone number | +447546456414 |
| Websites | |
| NAICS | 62 |
| SIC | 873 |
| Keywords | Health Economics, Health Technology Assessment, Health Economic Modelling, Pharmacoeconomics, Systematic Review, Heor, Epidemiological Data Analysis, Market Access And Reimbursement |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Optimax Access Email Formats
Optimax Access uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@optimaxaccess.com), used 57.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@optimaxaccess.com | 57.1% |
{first name}.{last name} | john.doe@optimaxaccess.com | 42.9% |
About Optimax Access
Optimax Access has a committed team of health economists and research analysts with more than 10 years’ international experience of the healthcare industry and health outcomes sector. Our multi-disciplinary team use our experience gained in the pharmaceutical industry, academia and health services worldwide to provide its clients with a comprehensive range of services related to health outcomes research. In Optimax Access we are proud to serve our clients. We offer a wide variety of evidence review and development projects to support your products and researches in our offices in the UK, US and Canada; the following are just a few examples: Review of Evidence • Systematic reviews and interpretation of clinical and economic evidence • Structured and targeted literature reviews (e.g. burden of illness, unmet needs assessments, health technology assessment (HTA)) • Network meta-analyses and indirect treatment comparisons Economic Evidence Development • Cost-effectiveness and cost-utility models • Early economic modelling and threshold analyses • Within-trial patient-level data analysis • Cohort models and individual patient-level simulations • Global economic models or HTA agency specific models • Adapting economic models to reflect intra-country and regional differences • Budget impact models • Survival modelling and extrapolation • Health outcome studies (Health-related quality of life/utility) Strategy Planning • Methodological and strategic advice • Portfolio planning • Preparation for formal HTA scientific advice • Critical review of your HTA submission • Review, critique and development of HEOR evidence generation plans (e.g. clinical trial design and outcomes assessment/instrument selection, payer evidence planning) • Review and critique of existing economic models and HTA evidence materials
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Optimax Access has 3 employees across 2 departments.
Departments
Number of employees
Funding Data
Optimax Access has never raised funding before.
Optimax Access Tech Stack
Discover the technologies and tools that power Optimax Access's digital infrastructure, from frameworks to analytics platforms.
Security
Analytics
JavaScript libraries
Maps
Analytics
Page builders
JavaScript libraries
Web servers
JavaScript libraries
Analytics
Advertising
United States
Switzerland
South Africa
BrazilFrequently asked questions
4.8
40,000 users
